LEXINGTON, Mass., Nov. 21, 2019 /PRNewswire/ -- (Booth #4111) – FUJIFILM Medical Systems U.S.A., Inc. a leading provider of diagnostic imaging products and medical informatics solutions, and part of the Fujifilm Healthcare portfolio, will present research and development advancements in Artificial Intelligence (AI)* for digital radiography at McCormick Place in Chicago during the 105th scientific assembly and annual meeting of the Radiological Society of North America (RSNA) from December 1 – 6, 2019.
"AI has the potential to bring a wealth of advancements to the medical imaging community," said Gregg R. Cretella, Director, Strategic Innovation, Modality Solutions, FUJIFILM Medical Systems U.S.A., Inc. "Fujifilm will showcase image processing technologies and the practical application of AI technologies to support diagnostic imaging and medical workflow. Combining AI technology with digital radiography can help identify surgical hardware and suspect findings. The technology can also position patients properly during exams. These advancements are designed to save valuable time, prevent exam retakes and speed clinician workflow."
Fujifilm continues to develop AI technologies that have the potential to support diagnostic imaging workflow, leveraging the combination of deep learning in its AI technology with Fujifilm's image processing heritage.
At RSNA, Fujifilm will demonstrate how its AI platform can be used in the Emergency Room, Operating Room and during general X-ray exams. Through these demonstrations, RSNA attendees will have the opportunity to witness how AI will influence the future of radiography.
Artificial Intelligence in the Emergency Room
AI in the ER will be demonstrated on the FDR AQRO mini mobile DR system*. AI-powered recognition algorithms could provide indications to physicians of suspicious findings. AI recognition will search and map images to help identify pathologies such as pneumothorax and more.
Artificial Intelligence in the Operating Room
AI in the OR will be demonstrated on the FDX Console*, which has the ability to be paired with Fujifilm mobile systems. The intelligent feature and density recognition are designed to highlight foreign objects such as surgical gauze for images acquired during or post-surgery.
Artificial Intelligence during General X-ray Exams
AI for positioning navigation will be demonstrated with a camera built into the collimator of a Fujifilm X-ray room. The system will match the exam menu selected for proper patient positioning and check for expected anatomy and/or anatomy orientation prior to exposure.
For more information about Fujifilm at RSNA or to schedule a product demonstration, please visit https://rsna.fujimed.com.
* Fujifilm AI integration for digital X-ray is in development and is not yet commercially available.
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions that meet the evolving needs of healthcare facilities both today and tomorrow. From an unrivaled selection of digital X-ray systems (DR: detectors, mobiles, and rooms), to the comprehensive Synapse® Enterprise Imaging portfolio, to full-field digital mammography systems with digital breast tomosynthesis, and computed tomography solutions, Fujifilm has products that are ideal for any size imaging environment. FUJIFILM Medical Systems U.S.A., Inc. – Endoscopy supplies high quality, technologically advanced endoscopic imaging solutions and devices to the medical field. Fujifilm's TeraMedica Division, the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management and the core to the Synapse Enterprise Imaging portfolio, enables improved interoperability by connecting imaging content across the entire care continuum. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Lexington, Massachusetts. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2019, the company had global revenues of $22 billion, at an exchange rate of 111 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.
SOURCE FUJIFILM Medical Systems U.S.A., Inc.